- Telehealth Visits
- Insurance plan information
Laura L. Koth, MD
Chronic Obstructive Pulmonary Disease • Interstitial Lung DiseaseCo-director, UCSF Interstitial Lung Disease Center of Excellence- Telehealth Visits
- Insurance plan information
Laura L. Koth, MD
Chronic Obstructive Pulmonary Disease • Interstitial Lung DiseaseCo-director, UCSF Interstitial Lung Disease Center of Excellence- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Laura Koth is a pulmonologist and an expert in interstitial lung disease. She is co-director of UCSF's interstitial lung disease center of excellence.
Koth's research activities focus on the mechanisms of lung inflammation and macrophage activation. Macrophages are a type of white blood cell with important roles in immune response.
Koth earned her medical degree from Harvard Medical School. She completed residency training in internal medicine at Massachusetts General Hospital, followed by a fellowship in pulmonary and critical care medicine UCSF. She joined the UCSF faculty in 2003.
Education & training
Board certification
- Pulmonary Disease, American Board of Internal Med/Pulmonary Disease
Fellowship
- UCSF Medical Center - OMAG
Residency
- Massachusetts General Hospital
Internship
- Massachusetts General Hospital
Degree
- MD, Harvard Medical School
My expertise
Specialties
- Chronic Obstructive Pulmonary Disease
- Interstitial Lung Disease
Conditions
- Idiopathic Pulmonary Fibrosis (IPF)
- Sarcoidosis
- Interstitial Lung Disease
- Hypersensitivity Pneumonitis
Locations
My work
Inside the Interstitial Lung Disease (ILD) Program
Clinical Trials query: q=health_gateway_id_ss%3A%28%22678%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22678%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.